GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Autonomix Medical Inc (NAS:AMIX) » Definitions » Interest Expense

Autonomix Medical (Autonomix Medical) Interest Expense : $ Mil (TTM As of Dec. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Autonomix Medical Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Autonomix Medical's interest expense for the three months ended in Dec. 2023 was $ -0.03 Mil. Autonomix Medical does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in Dec. 2023.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Autonomix Medical's Operating Income for the three months ended in Dec. 2023 was $ -2.92 Mil. Autonomix Medical's Interest Expense for the three months ended in Dec. 2023 was $ -0.03 Mil. Autonomix Medical did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Autonomix Medical Interest Expense Historical Data

The historical data trend for Autonomix Medical's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Autonomix Medical Interest Expense Chart

Autonomix Medical Annual Data
Trend
Interest Expense

Autonomix Medical Quarterly Data
Dec22 Dec23
Interest Expense - -0.03

Autonomix Medical Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Autonomix Medical  (NAS:AMIX) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Autonomix Medical's Interest Expense for the three months ended in Dec. 2023 was $-0.03 Mil. Its Operating Income for the three months ended in Dec. 2023 was $-2.92 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $1.46 Mil.

Autonomix Medical's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Autonomix Medical did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Autonomix Medical (Autonomix Medical) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Autonomix Medical Inc (NAS:AMIX) » Definitions » Interest Expense
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Autonomix Medical Inc is a development stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.